Streetbeat News

Products Services

BIIB

DNLI

B Riley Securities initiated coverage on Denali Therapeutics Inc (DNLI) with a Buy rating and a price target of $38. The analysts are optimistic about Denali's proprietary blood-brain barrier (BBB) shuttling platform approaches, which enables the safe, efficient, and effective delivery of complex large and small molecules. The emerging clinical datasets from DNLI's programs, whether independently owned or in collaboration, are anticipated to drive value in the coming quarters and years. Partnered programs, especially for Biogen Inc's (BIIB) ATV-Abeta (for Alzheimer's) and SAR443820 (for ALS), have been underestimated.

Portfolio Pulse from Vandana Singh

September 06, 2023 | 6:45 pm

PHG

RMD

Needham has upgraded ResMed Inc (RMD) from a Hold to Buy rating with a price target of $180. ResMed's shares are down 31% since August due to concerns about the potential for GLP-1 obesity drugs to reduce demand for ResMed's sleep therapy devices and Philips' (PHG) possible re-entry into the flow generator market. However, Needham believes that both impacts will likely be small and that ResMed can sustain 5-7% revenue growth above its large-cap peers.

Portfolio Pulse from Vandana Singh

September 06, 2023 | 6:39 pm

TSLA

A recent video demonstrates the performance capabilities of Tesla's Model S Plaid with an optional Track Package. This $20,000 upgrade allows the car to reach a top speed of 200 mph and accelerate from 0 to 60 mph in 1.99 seconds. The standard Model S Plaid has a top speed of 162 mph. The Autobahn test run showcases the Model S Plaid's ability to compete with traditional high-performance gasoline-powered vehicles.

Portfolio Pulse from Benzinga EV Insights

September 06, 2023 | 6:27 pm

FICO

Raymond James analyst Patrick O'Shaughnessy initiated coverage on Fair Isaac Corp (FICO) with an Outperform rating and a price target of $1,007. The analyst sees further upside for FICO's shares and expects strong execution in the Software segment to boost long-term revenue and margin. FICO's efforts to provide free FICO scores to consumers have boosted its brand. The company's focus on transitioning its Software business to a SaaS-based revenue model is seen as a growth driver.

Portfolio Pulse from Lekha Gupta

September 06, 2023 | 6:26 pm

AZN

JNJ

Johnson & Johnson's unit Janssen released topline results from the Phase 3 MARIPOSA-2 study evaluating Rybrevant regime versus chemotherapy alone, showing significant improvement in progression-free survival. The study enrolled patients with advanced or metastatic EGFR exon 19 deletions or L858R substitution NSCLC after disease progression on or after AstraZeneca's Tagrisso. JNJ shares are down 1.33% at $158.54.

Portfolio Pulse from Vandana Singh

September 06, 2023 | 6:11 pm

ATVI

Activision Blizzard Inc's Diablo 4 is planning to introduce annual expansions, according to its chief developer, Rod Fergusson. Despite some initial issues with Season 1, Diablo 4 had a successful launch in June. Season 2, titled Season of Blood, is set to launch on Oct. 17 and will include new content. Blizzard plans to use seasons for side quests, while expansions will drive the main storyline forward.

Portfolio Pulse from Franca Quarneti

September 06, 2023 | 6:02 pm

AMC

The concert film 'Taylor Swift: The Eras Tour' is expected to be a major hit at the box office, with cinema owners predicting a record $100M opening. The film will be shown in theaters across the U.S. and Canada for several weekends, starting from Oct. 13. AMC Theatres, the world's largest exhibitor, has secured distribution rights for the film and has partnered with indie distributor Variance to show the film in rival cinemas. AMC's presales for the film hit a record-breaking $26M within the first 24 hours.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 5:23 pm

PFE

Pfizer is developing a modified release GLP1 pill to reduce gastrointestinal effects, according to Bloomberg.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 5:22 pm

F

TSLA

Tesla's Model Y continues to lead the EV SUV market, but Ford's Mustang Mach-E has seen a strong rebound in sales, ranking second in August. Ford's sales were up 61.3% YoY with 5,033 units sold in August. However, year-to-date sales are down 10.7% YoY. Ford's F-150 Lightning sales dropped by 57.1% in August due to a factory shutdown. Ford's Q2 revenue for its EV segment was $1.8 billion, up 39% YoY. Ford's shares are down 2.03% to $11.84.

Portfolio Pulse from Chris Katje

September 06, 2023 | 5:19 pm

CYN

Cyngn has received a Notice of Allowance for its U.S. patent application 17/817,945 titled 'System And Methods Of Adaptive Traffic Rule-Based Decision Making For Autonomous Driving'.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 5:17 pm